Practical Management for Use of Eculizumab in the Treatment of Severe, Refractory, Non-Thymomatous, AChR + Generalized Myasthenia Gravis: A Systematic Review [Erratum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357556/
https://www.ncbi.nlm.nih.gov/pubmed/35958346
http://dx.doi.org/10.2147/TCRM.S384532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357556/
https://www.ncbi.nlm.nih.gov/pubmed/35958346
http://dx.doi.org/10.2147/TCRM.S384532

Ejemplares similares